R. L. Noble

3.3k total citations · 1 hit paper
40 papers, 2.3k citations indexed

About

R. L. Noble is a scholar working on Molecular Biology, Oncology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, R. L. Noble has authored 40 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Oncology and 9 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in R. L. Noble's work include Estrogen and related hormone effects (6 papers), Growth Hormone and Insulin-like Growth Factors (6 papers) and Cancer Treatment and Pharmacology (5 papers). R. L. Noble is often cited by papers focused on Estrogen and related hormone effects (6 papers), Growth Hormone and Insulin-like Growth Factors (6 papers) and Cancer Treatment and Pharmacology (5 papers). R. L. Noble collaborates with scholars based in Canada, United States and Australia. R. L. Noble's co-authors include Charles T. Beer, Peter W. Gout, Henry G. Friesen, Robert P. C. Shiu, Toshiaki Tanaka, J H Cutts, C. T. Beer, K. K. Carroll, Harry P. Elsholtz and Toshiaki Tanaka and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Pharmacological Reviews and Endocrinology.

In The Last Decade

R. L. Noble

40 papers receiving 2.1k citations

Hit Papers

A New Sensitive and Specific Bioassay for Lactogenic Horm... 1980 2026 1995 2010 1980 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A New Sensitive and Specific Bioassay for Lactogenic Hormones: Measurement of Prolactin and Growth Hormone in Human Serum*
    1980 503 citations Toshiaki Tanaka, Robert P. C. Shiu et al. The Journal of Clinical Endocrinology & Metabolism profile →

Peers

R. L. Noble
Thomas L. Dao United States
R. Hähnel Australia
Richard A. Hiipakka United States
Richard W. St. Clair United States
N. B. Myant United Kingdom
Mikio Shikita Japan
Anders Berkenstam Sweden
Wayne P. Bocchinfuso United States
Partha P. Banerjee United States
Margot M. Ip United States
Thomas L. Dao United States
R. L. Noble
Citations per year, relative to R. L. Noble R. L. Noble (= 1×) peers Thomas L. Dao

Countries citing papers authored by R. L. Noble

Since Specialization
Citations

This map shows the geographic impact of R. L. Noble's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. L. Noble with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. L. Noble more than expected).

Fields of papers citing papers by R. L. Noble

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. L. Noble. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. L. Noble. The network helps show where R. L. Noble may publish in the future.

Co-authorship network of co-authors of R. L. Noble

This figure shows the co-authorship network connecting the top 25 collaborators of R. L. Noble. A scholar is included among the top collaborators of R. L. Noble based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. L. Noble. R. L. Noble is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Carroll, Kenneth K. & R. L. Noble. (1987). Dietary fat in relation to hormonal induction of mammary and prostatic carcinoma in Nb rats. Carcinogenesis. 8(6). 851–853. 25 indexed citations
2.
Gout, Peter W., R. L. Noble, & Charles T. Beer. (1986). Cultured Nb rat lymphoma cells in endocrine and cancer research. Biochemistry and Cell Biology. 64(7). 659–666. 19 indexed citations
3.
Gout, Peter W., R. L. Noble, Nicholas Bruchovsky, & Charles T. Beer. (1984). Vinblastine and vincristine ‐ growth‐inhibitory effects correlate with their retention by cultured Nb 2 node lymphoma cells. International Journal of Cancer. 34(2). 245–248. 14 indexed citations
4.
Tanaka, Toshiaki, Yoshimasa Shishiba, Peter W. Gout, et al.. (1983). Radioimmunoassay and Bioassay of Human Growth Hormone and Human Prolactin*. The Journal of Clinical Endocrinology & Metabolism. 56(1). 18–20. 12 indexed citations
5.
Hughes, James P., Toshiaki Tanaka, Peter W. Gout, et al.. (1982). Effect of Iodination on Human Growth Hormone and Prolactin: Characterized by Bioassay, Radioimmunoassay, Radioreceptor Assay, and Electrophoresis*. Endocrinology. 111(3). 827–832. 16 indexed citations
6.
Noble, R. L., Charles T. Beer, & Peter W. Gout. (1980). Evidence in vivo and in vitro of a role for the pituitary in the growth of malignant lymphomas in Nb rats.. PubMed. 40(7). 2437–40. 48 indexed citations
7.
Tanaka, Toshiaki, Robert P. C. Shiu, Peter W. Gout, et al.. (1980). A New Sensitive and Specific Bioassay for Lactogenic Hormones: Measurement of Prolactin and Growth Hormone in Human Serum*. The Journal of Clinical Endocrinology & Metabolism. 51(5). 1058–1063. 503 indexed citations breakdown →
8.
Noble, R. L.. (1977). The development of prostatic adenocarcinoma in Nb rats following prolonged sex hormone administration.. VocBench (University of Rome Tor Vergata). 37(6). 1929–33. 276 indexed citations
9.
Noble, R. L., et al.. (1977). The distribution of [3H]vinblastine in tumor and host tissues of Nb rats bearting a transplantable lymphoma which is highly sensitive to the alkaloid.. PubMed. 37(5). 1455–60. 17 indexed citations
10.
Noble, R. L.. (1977). Hormonal control of growth and progression in tumors of Nb rats and a theory of action.. PubMed. 37(1). 82–94. 89 indexed citations
11.
Noble, R. L., et al.. (1975). A classification of transplantable tumors in Nb rats controlled by estrogen from dormancy to autonomy.. PubMed. 35(11 Pt 1). 2935–41. 39 indexed citations
12.
Noble, R. L., et al.. (1973). The Leeds regional quality control scheme for clinical biochemistry: A progress report. Journal of Clinical Pathology. 26(11). 875–880. 1 indexed citations
13.
Noble, R. L.. (1961). Vincaleukoblastine.. PubMed. 85. 610–1. 1 indexed citations
14.
Darte, J. M. M., et al.. (1960). Some biological effects of Vincaleukoblastine, an alkaloid in Vinca rosea Linn in patients with malignant disease.. PubMed. 20. 1032–40. 47 indexed citations
15.
Cutts, J H, C. T. Beer, & R. L. Noble. (1960). Biological properties of Vincaleukoblastine, an alkaloid in Vinca rosea Linn, with reference to its antitumor action.. PubMed. 20. 1023–31. 70 indexed citations
16.
Noble, R. L. & J H Cutts. (1959). Mammary tumors of the rat: a review.. PubMed. 19. 1125–39. 53 indexed citations
17.
Engel, Ch. R. & R. L. Noble. (1957). CONCERNING THE PROGESTATIONAL ACTIVITY OF 21-HAL0GENATED PROGESTERONES1. Endocrinology. 61(3). 318–321. 4 indexed citations
18.
Carroll, K. K. & R. L. Noble. (1956). ERUCIC ACID AND CHOLESTEROL EXCRETION IN THE RAT. Canadian Journal of Biochemistry and Physiology. 34(1). 981–991. 10 indexed citations
19.
Millar, M. J. & R. L. Noble. (1954). The Morphology and Growth Characteristics of a Transplantable Mammary Fibroadenoma in the Rat. British Journal of Cancer. 8(3). 485–494. 5 indexed citations
20.
Carroll, K. K. & R. L. Noble. (1952). EFFECTS OF FEEDING RAPE OIL ON SOME ENDOCRINE FUNCTIONS OF THE RAT. Endocrinology. 51(6). 476–486. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thomas L. Dao Breakdown of academic impact, for papers by R. Hähnel Breakdown of academic impact, for papers by Richard A. Hiipakka Breakdown of academic impact, for papers by Richard W. St. Clair Breakdown of academic impact, for papers by N. B. Myant Breakdown of academic impact, for papers by Mikio Shikita Breakdown of academic impact, for papers by Anders Berkenstam Breakdown of academic impact, for papers by Wayne P. Bocchinfuso Breakdown of academic impact, for papers by Partha P. Banerjee Breakdown of academic impact, for papers by Margot M. Ip
Rankless by CCL
2026